{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:29:00Z","timestamp":1790504940562,"version":"4.1.0"},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1070,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1111\/j.1365-2133.2012.11056.x","type":"journal-article","created":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T13:23:21Z","timestamp":1337174601000},"page":"804-814","source":"Crossref","is-referenced-by-count":73,"title":["Which outcomes should we measure in vitiligo? Results of a systematic review and a survey among patients and clinicians on outcomes in vitiligo trials"],"prefix":"10.1093","volume":"167","author":[{"given":"V.","family":"Eleftheriadou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.S.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Whitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Batchelor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Ravenscroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,9,26]]},"reference":[{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB1|cit1","first-page":"CD003263","article-title":"Interventions for vitiligo","volume":"1","author":"Whitton","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB2|cit2","unstructured":"COMET Initiative Core Outcome Measures in Effectiveness Trials http:\/\/www.comet-initiative.org"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","article-title":"The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force","volume":"20","author":"Taieb","year":"2007","journal-title":"Pigment Cell Res"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/archdermatol.2011.235","article-title":"Guidelines for designing and reporting clinical trials in vitiligo","volume":"147","author":"Gonzalez","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1745-6215-8-38","article-title":"OMERACT: an international initiative to improve outcome measurement in rheumatology","volume":"8","author":"Tugwell","year":"2007","journal-title":"Trials"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1371\/journal.pmed.0050096","article-title":"A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children","volume":"5","author":"Sinha","year":"2008","journal-title":"PLoS Med"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.1978.03280390079031","article-title":"Vitiligo. What is it? Is it important?","volume":"239","author":"Lerner","year":"1978","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB9|cit9","first-page":"1152","article-title":"How prominent are patient-reported outcomes in clinical trials of dermatological treatments?","volume":"159","author":"Townshend","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB10|cit10","first-page":"530","article-title":"Future research into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership","volume":"164","author":"Eleftheriadou","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1468-3083.2006.01420.x","article-title":"Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo","volume":"20","author":"Kumaran","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1468-3083.2006.02035.x","article-title":"Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study","volume":"21","author":"Bhatnagar","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-4632.2004.02403.x","article-title":"Efficacy of autologous transplantation of noncultured epidermal suspension in two different dilutions in the treatment of vitiligo","volume":"45","author":"Tegta","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archderm.143.5.578","article-title":"Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs narrowband-UV-B therapy","volume":"143","author":"Yones","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1468-3083.2008.02839.x","article-title":"A double-blind, randomized trial of 0\u00b705% betamethasone vs. topical catalase\/dismutase superoxide in vitiligo","volume":"22","author":"Sanclemente","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000083091","article-title":"Living with vitiligo: a controlled investigation into the effects of group cognitive-behavioural and person-centred therapies","volume":"5","author":"Papadopoulos","year":"2004","journal-title":"Dermatol Psychosom"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1523-1747.2003.12251.x","article-title":"Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring?","volume":"120","author":"Charman","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(09)60329-9","article-title":"Avoidable waste in the production and reporting of research evidence","volume":"374","author":"Chalmers","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0781.2008.00385.x","article-title":"Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study","volume":"24","author":"Anbar","year":"2008","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1346-8138.2006.00079.x","article-title":"Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo","volume":"33","author":"Arca","year":"2006","journal-title":"J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2340\/00015555-0469","article-title":"Targeted broadband ultraviolet B phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study","volume":"88","author":"Asawanonda","year":"2008","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1524-4725.2004.30003.x","article-title":"A comparative study of punch grafting followed by topical corticosteroid versus punch grafting followed by PUVA therapy in stable vitiligo","volume":"30","author":"Barman","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1468-3083.2007.02151.x","article-title":"Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313\u2003nm) in the treatment of vitiligo - a multicentre controlled study","volume":"21","author":"Casacci","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB24|cit24","first-page":"683","article-title":"Comparative study of two psoralens in topical phototherapy for vitiligo [Estudo comparativo entre dois psoralenos na fototerapia topica do vitiligo]","volume":"76","author":"Cestari","year":"2001","journal-title":"An Bras Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1524-4725.2004.30435.x","article-title":"Comparison of melanocytes transplantation methods for the treatment of vitiligo","volume":"30","author":"Czajkowski","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1610-0387.2006.06124.x","article-title":"Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study [Wirksamkeit und Sicherheit von Pimecrolimus-Creme 1% bei erwachsenen Patienten mit Vitiligo: Ergebnisse einer randomisierten, Vehikel-kontrollierten Doppelblind-Studie]","volume":"4","author":"Dawid","year":"2006","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2230.2007.02514.x","article-title":"Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial","volume":"32","author":"Dell\u2019Anna","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0781.2006.00229.x","article-title":"Ultraviolet A in vitiligo","volume":"22","author":"El-Mofty","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1365-2133.2001.04286.x","article-title":"Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study","volume":"145","author":"Ermis","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/09546630802155057","article-title":"The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial","volume":"20","author":"Esfandiarpour","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2133.1967.tb11461.x","article-title":"The treatment of vitiligo with psoralens and triamcinolone by mouth","volume":"79","author":"Farah","year":"1967","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1468-3083.2006.02016.x","article-title":"Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo","volume":"21","author":"Goldinger","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archderm.140.6.677","article-title":"Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index","volume":"140","author":"Hamzavi","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-2133.2004.06321.x","article-title":"Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients","volume":"152","author":"Hofer","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2133.1974.tb13086.x","article-title":"Treatment of vitiligo with 0\u00b71 per cent betamethasone 17-valerate in isopropyl alcohol - a double-blind trial","volume":"91","author":"Kandil","year":"1974","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1524-4725.2004.30058.x","article-title":"Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study","volume":"30","author":"Kawalek","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-4362.1995.tb01570.x","article-title":"Comparison of 0\u00b705% clobetasol propionate cream and topical Puvasol in childhood vitiligo","volume":"34","author":"Khalid","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00042728-200504000-00010","article-title":"Comparison of minipunch grafting versus split-skin grafting in chronic stable vitiligo","volume":"31","author":"Khandpur","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2230.2005.02037.x","article-title":"Tacalcitol and narrow-band phototherapy in patients with vitiligo","volume":"31","author":"Leone","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0\u00b71% tacrolimus vs 0\u00b705% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB41|cit41","first-page":"17","article-title":"Comparison between narrow-band UVB with topical corticosteroid and narrow-band UVB with placebo in the treatment of vitiligo: a randomized controlled trial","volume":"14","author":"Lim-Ong","year":"2005","journal-title":"J Philipp Dermatol Soc"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-0781.2006.00250.x","article-title":"Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo","volume":"22","author":"Lu-yan","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/archderm.142.7.927","article-title":"A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B plus 0\u00b71% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo","volume":"142","author":"Mehrabi","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1468-3083.2006.02132.x","article-title":"Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study","volume":"21","author":"Middelkamp-Hup","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB45|cit45","first-page":"260","article-title":"Autologous skin minigraft and ingestion of 8-methoxypsoralen in patients with stable vitiligo vulgaris","volume":"42","author":"Navarro","year":"2002","journal-title":"Dermatologia Rev Mex"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-4362.2002.01391.x","article-title":"Comparison of two surgical approaches for treating vitiligo: a preliminary study","volume":"41","author":"Ozdemir","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000017991","article-title":"Combination of PUVAsol and topical calcipotriol in vitiligo","volume":"197","author":"Parsad","year":"1998","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2230.2003.01207.x","article-title":"Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo","volume":"28","author":"Parsad","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archderm.140.9.1065","article-title":"Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo","volume":"140","author":"Passeron","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB50|cit50","first-page":"165","article-title":"Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5\u2032,8-trimethylpsoralen, and psoralen in vitiligo","volume":"66","author":"Pathak","year":"1984","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/09546639509097164","article-title":"Ineffectiveness of topical khellin in photochemotherapy of vitiligo","volume":"6","author":"Procaccini","year":"1995","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/09546630600791442","article-title":"The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients","volume":"17","author":"Radmanesh","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4103\/0378-6323.42905","article-title":"An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad\/narrow band UVB phototherapy in progressive vitiligo","volume":"74","author":"Rath","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jdermsci.2005.12.006","article-title":"Systemic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: a pilot study","volume":"41","author":"Reyes","year":"2006","journal-title":"J Dermatol Sci"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2133.2008.08906.x","article-title":"Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo","volume":"160","author":"Rodriguez-Martin","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB56|cit56","first-page":"21","article-title":"Evaluation of an antioxidant and mitochondrial stimulating cream formula in the skin of patients with stable vulgar vitiligo [Evaluacion de una formulacion antioxidante y estimuladora mitocondrial en piel de pacientes con vitiligo vulgar estable]","volume":"48","author":"Rojas-Urdaneta","year":"2007","journal-title":"Invest Clin"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB57|cit57","first-page":"513","article-title":"4-5-8 Trimethylpsoralen in vitiligo. Controlled study of its therapeutic and toxic effect in children [4-5-8 Trimetilpsoralen en vitiligo. Estudio controlado de su efecto terapeutico y toxico en los ninos]","volume":"66","author":"Ruiz Maldonado","year":"1975","journal-title":"Actas Dermosifiliogr"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB58|cit58","first-page":"1186","article-title":"Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck","volume":"159","author":"Sassi","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1365-4362.2002.01463.x","article-title":"Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS)","volume":"41","author":"Schallreuter","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000247142","article-title":"l-phenylalanine and UVA irradiation in the treatment of vitiligo","volume":"188","author":"Siddiqui","year":"1994","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11655-008-0303-1","article-title":"Clinical observation on the effect of Zengse Pill in treating patients with vitiligo of qi-stagnancy and blood-stasis syndrome type","volume":"14","author":"Shi","year":"2008","journal-title":"Chin J Integr Med"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/000155502320624113","article-title":"Treatment of vitiligo vulgaris with narrow band UVB (311\u2003nm) for one year and the effect of addition of folic acid and vitamin B12","volume":"82","author":"Tjioe","year":"2002","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archderm.140.10.1203","article-title":"Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo","volume":"140","author":"van Geel","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB64|cit64","first-page":"308","article-title":"Vitiligo and intralesional steroids","volume":"69","author":"Vasistha","year":"1979","journal-title":"Indian J Med Res"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archderm.135.9.1061","article-title":"Left-right comparison study of the combination of fluticasone propionate and UV-A vs. either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo","volume":"135","author":"Westerhof","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2133.2005.06556.x","article-title":"A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo","volume":"153","author":"Agarwal","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/jid.2011.238","article-title":"Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis?","volume":"132","author":"Twiss","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1365-2133.2012.10806.x","article-title":"Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis","volume":"166","author":"Fernandez-Penas","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11056.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4103\/0378-6323.26722","article-title":"Scoring systems in dermatology","volume":"72","author":"Bhor","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2012.11056.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2012.11056.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T12:38:02Z","timestamp":1713962282000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/167\/4\/804\/6614120"}},"subtitle":["Which outcomes should we measure in vitiligo?"],"short-title":[],"issued":{"date-parts":[[2012,9,26]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11056.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718010183.793476580","asserted-by":"object"}]},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9,26]]}}}